About us

 

Sysmex Inostics, a subsidiary of Sysmex Corporation, is a molecular diagnostics company that is a pioneer in blood-based cell-free tumor DNA oncology testing utilizing highly sensitive technologies such as OncoBEAM and SafeSEQ.

Our highly sensitive assays detect cancer-associated mutations to enable development of targeted therapies as well as novel applications for ctDNA analysis such as monitoring of disease response and recurrence. Sysmex Inostics has a CLIA-certified laboratory in Baltimore, Maryland and a GCP laboratory in Hamburg, Germany. We also provide testing services in China and Japan. In addition, OncoBEAM™ assays are offered through laboratories participating in our Centers of Excellence program in Europe, Asia Pacific and Latin America.

What we offer

Sysmex Inostics is a trusted partner to leading pharmaceutical companies, advancing their efforts to bring the most effective personalized cancer therapies to global markets. We offer:

  • Biomarker Assay Development
  • Analytical and Clinical Validation
  • Regulatory Registration/Approval
  • cGMP Manufacturing
  • GCP/CLIA certified laboratory
  • Project Management
  • Companion Diagnostic (CDx) Kit Development and Commercialization